摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl lauryl carbonate | 6222-09-9

中文名称
——
中文别名
——
英文名称
methyl lauryl carbonate
英文别名
1-dodecyl methyl carbonate;Carbonic acid, dodecyl methyl ester;dodecyl methyl carbonate
methyl lauryl carbonate化学式
CAS
6222-09-9
化学式
C14H28O3
mdl
——
分子量
244.375
InChiKey
HAWBZAVPHSULBJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    301.6±11.0 °C(Predicted)
  • 密度:
    0.906±0.06 g/cm3(Predicted)
  • 保留指数:
    1600

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    17
  • 可旋转键数:
    13
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    十二烷醇碳酸二甲酯 在 Novozyme 435 作用下, 反应 30.0h, 以90.2%的产率得到methyl lauryl carbonate
    参考文献:
    名称:
    Asymmetric organic carbonate synthesis catalyzed by an enzyme with dimethyl carbonate: a fruitful sustainable alliance
    摘要:
    我们成功开发了一种简单高效的生物过程,通过在本工作中进行Novozym 435介导的DMC和醇的酯化反应,实现了不对称有机碳酸酯的合成。在优化条件下(60°C,醇与DMC的摩尔比为1:12),碳酸酯的最高产率可达到95.6%。新工艺的另一个优点是,酶在经过九次回收后仍保留90%的原始活性。因此,它有潜力成为工业生产不对称有机碳酸酯的有效酶催化工艺。
    DOI:
    10.1039/c3ra43698e
点击查看最新优质反应信息

文献信息

  • Synthesis of non-symmetrical alkyl carbonates from alcohols and DMC over the nanocrystalline ZSM-5 zeolite
    作者:Durgaiah Chevella、Arun Kumar Macharla、Rammurthy Banothu、Krishna Sai Gajula、Vasu Amrutham、Murali Boosa、Narender Nama
    DOI:10.1039/c9gc00541b
    日期:——
    A novel heterogeneous acid (nanocrystalline ZSM-5) catalyzed carboxymethylation of alcohols to non-symmetrical alkyl carbonates using DMC has been realized. Nanocrystalline ZSM-5 (NZSM-5) with a crystal size of 20–30 nm was synthesized by hydrothermal crystallization. The synthesized NZSM-5 was verified by X-ray diffraction, Fourier transformation infrared spectroscopy and solid state NMR. The morphology
    已经实现了使用DMC的新型异质酸(纳米晶体ZSM-5)催化醇的羧甲基化为不对称的碳酸烷基酯。通过水热结晶合成了晶体大小为20–30 nm的纳米晶体ZSM-5(NZSM-5)。合成的NZSM-5通过X射线衍射,傅立叶变换红外光谱和固态NMR进行验证。透射电子显微镜和扫描电子显微镜证实了NZSM-5的形态,揭示了由纳米大小(20-30 nm)的NZSM-5颗粒堆积形成的沸石(100-200 nm)聚集体的形成。NZSM-5的理化性质通过氮的吸附和程序升温的氨解吸来测量,这表明表面积为465 m 2 g -1酸度为0.936 mmol g -1。本协议为高产量的各种非对称碳酸烷基酯提供了一种有吸引力的方法。催化剂被有效地循环多达5个连续循环。这种方法拓宽了DMC在绿色化学中可能的利用范围。
  • 一种不对称长链单烷基碳酸酯的合成方法及 其应用
    申请人:太原理工大学
    公开号:CN109180488B
    公开(公告)日:2021-08-10
    本发明公开了一种不对称长链单烷基碳酸酯的合成方法及其应用,属于有机化学领域。本发明以脂肪醇和碳酸二烷基酯为原料,在固体催化剂存在下进行酯交换反应制备不对称长链单烷基碳酸酯。所述固体催化剂由含镁、磷和钾元素的可溶性盐通过水热法‑高温焙烧制得,该催化剂对酯交换法合成不对称长链单烷基碳酸酯反应具有良好的催化活性和优良的选择性,不对称长链单烷基碳酸酯的收率可达90%以上,选择性可达98%以上。所得到的产物不对称长链单烷基碳酸酯作为润滑油基础油具有优异的润滑性能。本发明方法所用催化剂制备过程简单、易于分离回收、节能环保、对设备无腐蚀,所得产物不对称长链单烷基碳酸酯是一种性能优良的润滑油基础油。
  • Antibacterial compound
    申请人:SANKYO COMPANY, LIMITED
    公开号:US20030171330A1
    公开(公告)日:2003-09-11
    A compound of formula (I) 1 wherein R 1 and R 2 represent a hydrogen atom or an aryl, a heterocyclic, an alkyl or an alkenyl, which are optionally substituted, R 3 represents a hydrogen atom or a hydroxyl and X 1 and X 2 represent an oxygen atom, a sulfur atom or a nitrogen containing group, a pharmaceutically acceptable derivative thereof or a salt thereof. A pharmaceutical composition comprising the compound for the prevention or treatment of a bacterial infection. A method for the prevention or treatment of a bacterial infection in a warm-blooded animal comprising administering a pharmacologically effective amount of the compound.
    式(I)的化合物,其中R1和R2代表氢原子或芳基、杂环基、烷基或烯基,可以是可选择取代的;R3代表氢原子或羟基;X1和X2代表氧原子、硫原子或含氮基团,其药用上可接受的衍生物或盐。包括该化合物的药物组合物,用于预防或治疗细菌感染。一种方法,用于在温血动物中预防或治疗细菌感染,包括给予该化合物的药理有效量。
  • FUNCTIONALIZED FLUOROPOLYMERS AND ELECTROLYTE COMPOSITIONS
    申请人:Blue Current, Inc.
    公开号:US20160221926A1
    公开(公告)日:2016-08-04
    Provided herein are functionally substituted fluoropolymers suitable for use in liquid and solid non-flammable electrolyte compositions. The functionally substituted fluoropolymers include perfluoropolyethers (PFPEs) having high ionic conductivity. Also provided are non-flammable electrolyte compositions including functionally substituted PFPEs and alkali-metal ion batteries including the non-flammable electrolyte compositions.
    本文提供了功能性取代的氟聚合物,适用于液体和固体的无火电解质组成。这些功能性取代的氟聚合物包括具有高离子导电性的全氟聚醚(PFPEs)。还提供了包括功能性取代的PFPEs的无火电解质组成和碱金属离子电池,其中包括了这种无火电解质组成。
  • N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound
    申请人:Shinohata Masaaki
    公开号:US20110133121A1
    公开(公告)日:2011-06-09
    The present invention is a method for producing an N-substituted carbamic acid ester derived from an organic amine from an organic amine, a carbonic acid derivative and a hydroxy composition containing one or more types of hydroxy compounds, wherein the organic amine, the carbonic acid derivative and the hydroxy composition are reacted using a urethane production reaction vessel provided with a condenser, a gas containing the hydroxy composition, the compound having the carbonyl group derived from the carbonic acid derivative, and an ammonia formed as a by-product in the reaction, is introduced into the condenser provided in the urethane production reaction vessel, and the hydroxy composition and the compound having the carbonyl group derived from the carbonic acid derivative are condensed, and wherein a stoichiometric ratio of a hydroxy compound contained in the condensed hydroxy composition to the condensed compound having the carbonyl group derived from the carbonic acid derivative is 1 or more, and a ratio of number of carbonyl groups (—C(═O)—) contained in the compound having the carbonyl group derived from the carbonic acid derivative and number of ammonia molecules contained in the ammonia recovered as a gas from the condenser is 1 or less.
    本发明涉及一种从有机胺、碳酸衍生物和含有一种或多种羟基化合物中制得的N-取代氨基甲酸酯的制备方法,其中使用一种含有冷凝器的脲类生产反应容器反应有机胺、碳酸衍生物和羟基化合物,将含有羟基化合物的气体、来自碳酸衍生物衍生的含有羰基基团的化合物、以及在反应中形成的氨气体引入到脲类生产反应容器中的冷凝器中,使羟基化合物和含有羰基基团的化合物冷凝,其中在冷凝的羟基化合物中所含有的羟基化合物与冷凝的含有羰基基团的化合物中所含有的羰基基团的化合物的比例为1或更多,而且在从冷凝器中回收的氨气体中所含有的羰基基团(—C(═O)—)数与氨分子数的比例为1或更少。
查看更多